Table 1.
Demographic Character of Gynecologic Oncology Cases and VTE
| VTE (n=29) * |
Non VTE (n=363) * | p-value | |
|---|---|---|---|
| Age(year)** | 58.1±14.1 | 56.2±12.2 | 0.424 |
| BMI (kg/m2) ** | 24.2±4.5 | 25.1±5.5 | 0.384 |
| Menopause | 22 (75.8) | 246 (67.7) | 0.37 |
| Nulliparous | 10 (34.4) | 113 (31.1) | 0.71 |
| Underlying disease | |||
| Hypertension | 13 (44.8) | 129 (35.5) | 0.32 |
| Diabetes | 4 (13.8) | 52 (14.33) | 0.97 |
| Advanced stage | 13 (44.8) | 87 (23.9) | 0.013 |
| Operation time (min)** | 174.7±45.0 | 175.2±57.7 | 0.962 |
| Suboptimal | 7 (24.1) | 58 (16.0) | 0.256 |
| Node dissection | 25 (86.2) | 292 (80.04) | 0.447 |
| Uterine cancer | 15 (51.7) | 177 (48.7) | 0.76 |
| Non-endometrioid | 8 (53.3) | 38 (21.5) | 0.005 |
| Ovarian cancer | 11 (37.8) | 128 (35.2) | 0.77 |
| Clear cell | 5 (50) | 33 (25.7) | 0.09 |
| Cervical cancer | 3 (11.4) | 50 (13.77) | 0.603 |
| Caprini score | 6.4±1.6 | 5.7±0.97 | <0.05 |
| Hemoglobin(gm%) ** | 11.4±1.5 | 11.8±1.6 | 0.293 |
| WBC (cells/mm3) ** | 8,455±4767 | 8038±3375 | 0.537 |
| Platelets (cells/mm3) ** | 358.6±168.0 | 310.1±110 | 0.029 |
| Albumin(gm%) ** | 3.5±0.7 | 3.8±0.6 | 0.016 |
| PLR** | 23.2±35.2 | 15.2±14.7 | 0.016 |
*n (%), **mean ±standard deviation (SD), VTE, venous thromboembolism; n (%), number of patient (percent); BMI, body mass index; Advanced stage, FIGO stage 3-4; PLR, platelet lymphocyte ratio